ARTICLE
30 November 2016

Chief Judge Stark Denies Defendant's Motion To Continue Trial And Issues Rulings On Motions In Limine In Patent Infringement Action

By Memorandum Order entered by The Honorable Leonard P. Stark in Idenix Pharmaceuticals LLC, et al. v. Gilead Sciences, Inc., et al., the Court denied Defendant's motion...
United States Intellectual Property
To print this article, all you need is to be registered or login on Mondaq.com.

By Memorandum Order entered by The Honorable Leonard P. Stark in Idenix Pharmaceuticals LLC, et al. v. Gilead Sciences, Inc., et al., Civil Action No. 13-1987-LPS (D.Del., November 22, 2016) (consolidated), the Court denied Defendant's motion requesting a continuance of the scheduled December 2016 trial and issued its ruling on certain motions in limine filed by the parties. The Court also forecasted that it would allocate each side between eighteen (18) and twenty-two (22) hours for its trial presentation, with the specific amount to be discussed further at the pretrial conference. Id. at *3. The Court also instructed the parties that, other than during jury selection, jury instructions, and argument regarding jury instructions, some party will be charged for any time the Court is on the bench. Id. at *2-3.

A copy of the Memorandum Order is attached.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

ARTICLE
30 November 2016

Chief Judge Stark Denies Defendant's Motion To Continue Trial And Issues Rulings On Motions In Limine In Patent Infringement Action

United States Intellectual Property
Contributor
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More